Our Firm is currently representing plaintiffs who allege injuries due to Xeralto usage. The litigation surrounding this medication is likely to be large, and appropriate for the type of centralization ordered by the Panel.
New York, New York (PRWEB) December 15, 2014
The U.S. Judicial Panel on Multidistrict Litigation has decided to centralize all federally-filed Xarelto lawsuits (http://www.xareltolawsuit2015.com/) in a single proceeding to be established in the U.S. District Court, Eastern District of Louisiana, Bernstein Liebhard LLP reports. According to a Transfer Order issued by the Panel on December 12th, at least 21 Xarelto cases have been filed in federal courts that allege the medication caused plaintiffs to experience dangerous internal bleeding and other serious complications. While the JPML acknowledged that the pending lawsuits did “present a number of individualized factual issues,” the members found that the docket would benefit from centralization because plaintiffs also raise numerous common issues, “including the adequacy of Xarelto’s warning label as to the risk of severe bleeding, the results of certain clinical studies, and the alleged need for blood monitoring.” (In Re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 2592)
“Our Firm is currently representing plaintiffs who allege injuries due to Xeralto usage. The litigation surrounding this medication is likely to be large, and appropriate for the type of centralization ordered by the Panel,” said Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free, no-obligation Xarelto case reviews to people who allegedly suffered serious injuries from the blood thinner, including uncontrollable bleeding, strokes, deep vein thrombosis or pulmonary embolism.
According to court documents, all of the Xarelto lawsuits currently pending in federal court allege that the drug’s manufacturers wrongly marketed it as a superior alternative to warfarin. Among other things, the complaints point out that there currently exists no approved antidote to reverse Xarelto bleeding, while the internal bleeding that may sometime occur with warfarin can be stopped via the administration of vitamin K. The lawsuits also claim that the drug makers should have recommended blood monitoring for Xarelto patients, so that physicians could adjust dosage to avoid high concentrations that have the potential to lead to life-threatening internal hemorrhaging.
In October, a number of Xarelto plaintiffs petitioned the JPML for consolidation of all federally-filed claims, asserting that thousands of additional cases would eventually be filed by individuals who were allegedly harmed by the medication. Consolidation of the Xarelto docket will allow the cases to undergo coordinated pretrial proceedings, thereby avoiding duplicative discovery and inconsistent court rulings. The establishment of the multidistrict litigation will also preserve the resources of the Court, parties and witnesses.
Xarelto patients who were allegedly harmed by the blood thinner may be entitled to recover compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a Xarelto lawsuit, please visit Bernstein Liebhard LLPs website, or call 800-511-5092 to schedule a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP